Catalent vs Minaris Advanced Therapies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/catalent/wuxi-advanced-therapies

Category	Catalent	Minaris Advanced Therapies
Listed site	cdmo	cdmo
Summary	Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.	Pure-play cell and gene therapy CDMO with over 25 years of GMP manufacturing, process development, and biosafety testing expertise. Serves advanced therapy innovators globally from early stage through commercialization.
Services	Cell Therapy Manufacturing Viral Vector Manufacturing AAV Manufacturing Oral Solid Dosage Manufacturing Inhalation & Nasal Dosage Manufacturing Formulation Development Process Development CMC Analytical Development Technology Transfer Sterile Fill-Finish & Aseptic Manufacturing Quality Control Testing Recombinant Protein Manufacturing Biologics Development & Manufacturing API Synthesis & Manufacturing Small Molecule Development & Manufacturing Monoclonal Antibody (mAb) Manufacturing Secondary Packaging & Labeling Stability Testing & Storage CMC Regulatory Submission Support Allogeneic Cell Therapy Manufacturing Autologous Cell Therapy Manufacturing Cell-Line Development Upstream Processing Downstream Processing Vial Filling Prefilled Syringe (PFS) Filling Topical & Semi-Solid Manufacturing Serialization & Track-and-Trace Cold-Chain Storage & Logistics Cartridge Filling Lyophilization (Freeze Drying) Lentiviral Vector Manufacturing	Cell Therapy Manufacturing Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Viral Vector Manufacturing AAV Manufacturing Lentiviral Vector Manufacturing Cell-Line Development Technology Transfer Process Development CMC Analytical Development Stability Testing & Storage Quality Control Testing Vaccine Manufacturing Monoclonal Antibody (mAb) Manufacturing Recombinant Protein Manufacturing
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy AAV / Viral Vector Platform	Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine AAV / Viral Vector Platform
Indications	Data not yet provided.	Data not yet provided.
Locations	Headquarters, United States Asia Pacific, Asia Pacific Europe, Europe Latin America, Latin America North America, North America, United States China, China Japan, Japan North America, North America Headquarters / Global Operations Cell Therapy Center of Excellence, Princeton, New Jersey, United States Soft Chew Manufacturing, Manassas, Virginia, United States Global Network	Headquarters, Philadelphia, PA, United States Philadelphia, Philadelphia, PA, United States Allendale, Allendale, NJ, United States Taufkirchen, Taufkirchen, Bavaria, Germany London, London, England, United Kingdom Yokohama, Yokohama, Kanagawa, Japan Manufacturing & Testing, Philadelphia, PA, United States Manufacturing, Allendale, NJ, United States Manufacturing, Taufkirchen, Bavaria, Germany Office, London, England, United Kingdom Manufacturing, Yokohama, Kanagawa, Japan Manufacturing & Testing, Allendale, NJ, United States Manufacturing & Testing, Taufkirchen, Bavaria, Germany Manufacturing & Testing, Yokohama, Kanagawa, Japan
Certifications	GMP · Identifier: Nine GMP facilities FDA · Identifier: 21 CFR 111 FDA · Identifier: 21 CFR 117	FDA · Identifier: Commercial manufacturing approval EMA · Identifier: Commercial manufacturing approval PMDA · Identifier: Commercial manufacturing approval FDA · Identifier: FDA approval for commercial manufacturing EMA · Identifier: EMA approval for commercial manufacturing PMDA · Identifier: PMDA approval for commercial manufacturing
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.